At a Capitol Hill event organized by AAAS, experts discussed the legal challenges facing the fast-growing industry.

Researchers say the device can be reconfigured to test for a wide range of conditions, from diagnosing cancer to monitoring diabetes.

The emerging ability to detect changes in the brain linked to Alzheimer’s disease gives scientists the prospect of developing preventive measures for the devastating disorder, a leading specialist on the disease told a recent gathering at AAAS.

Dr. Reisa A. Sperling, director of the Center for Alzheimer’s Research and Treatment at the Harvard Medical School, said there has been some “very exciting research” recently which suggests that the preclinical process of Alzheimer’s typically is underway for 10 or even 20 years before detectable symptoms.